Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myeloproliferative Disorders 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Hodgkin Disease 11Lymphoma, Non-Hodgkin 10Multiple Myeloma 9Leukemia, Myeloid, Chronic-Phase 9Lymphoma, Large B-Cell, Diffuse 8Waldenstrom Macroglobulinemia 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Leukemia 5Burkitt Lymphoma 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

fludarabine phosphate 6Whole-Body Irradiation 6Melphalan 5Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Antibodies 4Cyclophosphamide 3thymoglobulin 2Tacrolimus 2Methotrexate 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2merphos 1fludarabine 1Transplantation, Homologous 1Thiotepa 1Sirolimus 1Rituximab 1Observation 1Muromonab-CD3 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Drug Therapy 1Cyclosporins 1Basiliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemoglobinuria, Paroxysmal × Cyclosporins × Myeloid × Clear all
NCT00397813 2020-01-31

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

Fred Hutchinson Cancer Center

Phase 2 Completed
77 enrolled 16 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Hemoglobinuria, Paroxysmal, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡